Climb Bio (CLYM) Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization
Climb Bio Inc (CLYM) specializes in targeted therapy for rare kidney and immune pathologies, holding the rights to budegalimab. This daily price chart on GURU.Markets, where the metric stands at 0.00, visualizes the progress of these developments. The company is creating selective B-cell depletion methods to combat autoimmune failures. Since the drugs are currently in the trial stage, there is no commercial revenue, and the market capitalization depends on the test results.
climbbio.com - analytical breakdowns and key metrics (CLYM)
- current price and projected stock value:
- market capitalization details:
- book value of equity indicators:
- debt level and financial liquidity data:
- business earnings and investment ratios data:
CLYM - Net Financial Result|Expected Profit Climb Bio Inc|CLYM - Price to Earnings Ratio|Forward P/E Multiple Climb Bio Inc|CLYM - Price/Earnings to Growth Ratio|Enterprise Value to EBITDA Ratio Climb Bio, Inc|CLYM - Income before deduction of interest, taxes and amortization|Net earnings per share (EPS TTM) Climb Bio|CLYM - Earnings per share for the last twelve months|Quarterly EPS earnings growth climbbio.com|CLYM - Expected net earnings per share growth this year|Net earnings per share growth forecast for next year Climb Bio Inc
Initial company analysis:Climb Bio, Inc. CLYM
Climb Bio Inc (CLYM) specializes in high-risk immunotherapy developments for the treatment of autoimmune pathologies. This metric correlates the total enterprise value, including net debt, with operating profit before depreciation and interest. It allows for an assessment of the real value of assets relative to the ability to generate cash flow. The trend of the company's EV/EBITDA multiple is critical for analyzing stability amid a constant need for new capital.
Competitors of Climb Bio Inc (CLYM)
EV/EBITDA Multiple ARGX (Argenx)|Total Company Value to Operating Income Before Depreciation Ratio BioNTech Pharma (BNTX)|ABVX - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|admabiologics.com (ADMA) - Enterprise Value to EBITDA Ratio|Protagonist (PTGX) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to EBITDA Ratio Immunovant Inc|Enterprise Value to EBITDA Ratio KNSA|EV/EBITDA Multiple Grifols Biemat|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Adaptive Biotechnologies (ADPT)|celldex.com - Enterprise Value to Operating Income Before Depreciation|EV/EBITDA Multiple AUPH (Aurinia Pharmaceuticals Inc.)|BioCryst Pharmaceuticals, Inc. (BCRX) - Company Value to EBITDA|Vera Pharma - EV/EBITDA Multiple|Dianthus Corp (DNTH) - Enterprise Value to EBITDA Ratio|Pharvaris N.V. (PHVS) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|ABCL (AbCellera) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|TRML (Tourmaline Bio) - EV/EBITDA Multiple|Precigen Inc (PGEN) - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Pharming (PHAR)|Enterprise Value to EBITDA Ratio Nektar Corp NKTR|EV/EBITDA Multiple UPB (Upstream Bio Inc)|zenasbio.com - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|IMNM: Enterprise Value to EBITDA Ratio|Business Value to Operating Income Before Depreciation GOSS (Gossamer Bio Inc)|KALV: EV/EBITDA Multiple|SEPN (Septerna Pharma) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|PVLA (Pieris Pharmaceuticals) - EV/EBITDA Multiple|savarapharma.com (SVRA) - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Rigel Pharmaceuticals, Inc. (RIGL)|ANAB - Company Value to EBITDA|Astria Pharma - Enterprise Value to EBITDA Ratio|Business Value to Operating Income Before Depreciation ENGN|RAPT Therapeutics - EV/EBITDA Multiple|Total Company Value to Operating Income Before Depreciation Ratio Aerovate Therapeutics Inc JBIO|Aclaris Therapeutics, Inc. (ACRS) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to Operating Income Before Depreciation KYTX|TLSA (Tiziana Life Sciences PLC) - EV/EBITDA Multiple|Enterprise Value to EBITDA Ratio Cabaletta Bio Inc (CABA)|EV/EBITDA Multiple VTYX|Enterprise Value to EBITDA Ratio theratech.com THTX|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Avalo Therapeutics AVTX|Eledon Pharmaceuticals Inc. - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|AGEN: Enterprise Value to EBITDA Ratio|Company Value to EBITDA zurabio.com|aTyr Pharma, Inc. (ATYR) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to EBITDA Ratio Adagene Inc.|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization ImageneBio|Shattuck Therapeutics - Company Value to Operating Income Before Depreciation Ratio|EV/EBITDA Multiple EQ|CNTB (connectbiopharm.com) - Business Value to Operating Income Before Depreciation|EV/EBITDA Multiple IMUX (Immunic)|EV/EBITDA Multiple Atara Biotherapeutics, Inc. ATRA|IFRX - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Business Value to Operating Income Before Depreciation XFOR (X4 Pharmaceuticals Inc.)|adicetbio.com (ACET) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to EBITDA Ratio Celularity|INMB (INmune Bio, Inc.) - EV/EBITDA Multiple|EV/EBITDA Multiple barinthusbio.com|Enterprise Value to EBITDA Ratio KZR (Kezar Life Sciences, Inc.)|SABS (SAB Biotherapeutics Inc.) - Business Value to Operating Income Before Depreciation|EV/EBITDA Multiple AKTX (Akari Therapeutics plc)|Total Company Value to Operating Income Before Depreciation Ratio Enlivex Therapeutics Ltd (ENLV)|QTTB - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|geovax.com (GOVX) - Enterprise Value to EBITDA Ratio|Edesa Biotech (EDSA) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to EBITDA Ratio iBio Inc|Enterprise Value to EBITDA Ratio CARM|EV/EBITDA Multiple XTL Bio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Bolt Biotherapeutics (BOLT)|hcwbiologics.com - Enterprise Value to Operating Income Before Depreciation|EV/EBITDA Multiple APVO (Aptevo Therapeutics Inc.)|aimimmuno.com (AIM) - Company Value to EBITDA|Aditxt Corp - EV/EBITDA Multiple|GRI Bio Corporation (GRI) - Enterprise Value to EBITDA Ratio|XORTX Therapeutics Inc. (XRTX) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|HIND (reshapelifesciences.com) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|REVB (Revelation Biosciences, Inc.) - EV/EBITDA Multiple|Indaptus Therapeutics Inc (INDP) - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Scinai (SCNI)|Enterprise Value to EBITDA Ratio calcimedica.com CALI|EV/EBITDA Multiple AFMD (Affimed N.V.)|Allakos Inc - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|HOOK: Enterprise Value to EBITDA Ratio|Business Value to Operating Income Before Depreciation IGMS (IGM Biosciences, Inc.)|ITOS: EV/EBITDA Multiple|OCEA (Ocean Biomedical Corp) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|TCBP (TC Biopharm) - EV/EBITDA Multiple|thirdharmonicbio.com (THRD) - Total Company Value to Operating Income Before Depreciation Ratio
